Fig. 3From: Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trialBaseline differential gene expression and pathway enrichment analysis. a Baseline sample tree: blue improvers, orange non-improvers. b Sample genes differentially expressed at baseline between improvers and non-improvers. c Pathways differentially expressed at baseline between improvers and non-improversBack to article page